4//SEC Filing
Atkins Michael B. 4
Accession 0000950170-24-002214
CIK 0001785530other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:19 PM ET
Size
5.3 KB
Accession
0000950170-24-002214
Insider Transaction Report
Form 4
Atkins Michael B.
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-04+35,000→ 35,000 totalExercise: $5.25Exp: 2034-01-03→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option was granted on January 4, 2024. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0002004793
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:19 PM ET
- Size
- 5.3 KB